156 related articles for article (PubMed ID: 32012278)
1. Quetiapine dose optimisation during gestation: a pharmacokinetic modelling study.
Badhan RKS; Macfarlane H
J Pharm Pharmacol; 2020 May; 72(5):670-681. PubMed ID: 32012278
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of the impact of CYP3A5 A6986G polymorphism on quetiapine pharmacokinetics by simulation of target attainment.
Shilbayeh SA; Sy SK; Melhem M; Zmeili R; Derendorf H
Clin Pharmacol Drug Dev; 2015 Sep; 4(5):387-94. PubMed ID: 27137148
[TBL] [Abstract][Full Text] [Related]
3. Population Pharmacokinetics Analysis of Quetiapine Extended-release Formulation in Japanese Patients with Bipolar Depression.
Fukushi R; Nomura Y; Katashima M; Komatsu K; Sato Y; Takada A
Clin Ther; 2020 Jun; 42(6):1067-1076.e2. PubMed ID: 32518042
[TBL] [Abstract][Full Text] [Related]
4. Development of physiologically based pharmacokinetic model to evaluate the relative systemic exposure to quetiapine after administration of IR and XR formulations to adults, children and adolescents.
Johnson TN; Zhou D; Bui KH
Biopharm Drug Dispos; 2014 Sep; 35(6):341-52. PubMed ID: 24797229
[TBL] [Abstract][Full Text] [Related]
5. A Single-Dose Crossover Pharmacokinetic Comparison Study of Oral, Rectal and Topical Quetiapine in Healthy Adults.
Leung JG; Nelson S; Cunningham JL; Thompson VH; Bobo WV; Kung S; Dierkhising RA; Plevak MF; Lapid MI
Clin Pharmacokinet; 2016 Aug; 55(8):971-6. PubMed ID: 26873228
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of quetiapine and 7-hydroxyquetiapine in hair roots and blood after a single dose of quetiapine.
Yan H; Ji JJ; Xiang P; Shen M
Forensic Sci Int; 2020 Apr; 309():110189. PubMed ID: 32109844
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics of quetiapine: an atypical antipsychotic.
DeVane CL; Nemeroff CB
Clin Pharmacokinet; 2001; 40(7):509-22. PubMed ID: 11510628
[TBL] [Abstract][Full Text] [Related]
8. Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics.
Grimm SW; Richtand NM; Winter HR; Stams KR; Reele SB
Br J Clin Pharmacol; 2006 Jan; 61(1):58-69. PubMed ID: 16390352
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetic modeling of quetiapine after administration of seroquel and seroquel XR formulations to Western and Chinese patients with schizophrenia, schizoaffective disorder, or bipolar disorder.
Zhou D; Bui KH; Li J; Al-Huniti N
J Clin Pharmacol; 2015 Nov; 55(11):1248-55. PubMed ID: 25975812
[TBL] [Abstract][Full Text] [Related]
10. Dosing Recommendations for Quetiapine When Coadministered With HIV Protease Inhibitors.
Sampson MR; Cao KY; Gish PL; Hyon K; Mishra P; Tauber W; Zhao P; Zhou EH; Younis IR
J Clin Pharmacol; 2019 Apr; 59(4):500-509. PubMed ID: 30452774
[TBL] [Abstract][Full Text] [Related]
11. Determination of plasma concentration reference ranges for oral aripiprazole, olanzapine, and quetiapine.
Korell J; Green B; Rae A; Remmerie B; Vermeulen A
Eur J Clin Pharmacol; 2018 May; 74(5):593-599. PubMed ID: 29392351
[TBL] [Abstract][Full Text] [Related]
12. The effect of multiple doses of cimetidine on the steady-state pharmacokinetics of quetiapine in men with selected psychotic disorders.
Strakowski SM; Keck PE; Wong YW; Thyrum PT; Yeh C
J Clin Psychopharmacol; 2002 Apr; 22(2):201-5. PubMed ID: 11910267
[TBL] [Abstract][Full Text] [Related]
13. A Lack of Systemic Absorption Following the Repeated Application of Topical Quetiapine in Healthy Adults.
Kayhart B; Lapid MI; Nelson S; Cunningham JL; Thompson VH; Leung JG
Am J Hosp Palliat Care; 2018 Aug; 35(8):1076-1080. PubMed ID: 29343085
[TBL] [Abstract][Full Text] [Related]
14. Effect of a dosing-time on quetiapine-induced acute hyperglycemia in mice.
Kapse S; Ando H; Fujiwara Y; Suzuki C; Ushijima K; Kitamura H; Hosohata K; Kotani K; Shimba S; Fujimura A
J Pharmacol Sci; 2017 Mar; 133(3):139-145. PubMed ID: 28279595
[TBL] [Abstract][Full Text] [Related]
15. Effect of fluoxetine and imipramine on the pharmacokinetics and tolerability of the antipsychotic quetiapine.
Potkin SG; Thyrum PT; Alva G; Carreon D; Yeh C; Kalali A; Arvanitis LA;
J Clin Psychopharmacol; 2002 Apr; 22(2):174-82. PubMed ID: 11910263
[TBL] [Abstract][Full Text] [Related]
16. Dose Adjustment of Quetiapine and Aripiprazole for Pregnant Women Using Physiologically Based Pharmacokinetic Modeling and Simulation.
Zheng L; Tang S; Tang R; Xu M; Jiang X; Wang L
Clin Pharmacokinet; 2021 May; 60(5):623-635. PubMed ID: 33251573
[TBL] [Abstract][Full Text] [Related]
17. 4β-Hydroxycholesterol level significantly correlates with steady-state serum concentration of the CYP3A4 substrate quetiapine in psychiatric patients.
Gjestad C; Haslemo T; Andreassen OA; Molden E
Br J Clin Pharmacol; 2017 Nov; 83(11):2398-2405. PubMed ID: 28585378
[TBL] [Abstract][Full Text] [Related]
18. Semi-Mechanistic Pharmacokinetic Modeling of Lipid Core Nanocapsules: Understanding Quetiapine Plasma and Brain Disposition in a Neurodevelopmental Animal Model of Schizophrenia.
Carreño F; Helfer VE; Staudt KJ; Olivo LB; Paese K; Meyer FS; Herrmann AP; Guterres SS; Kuze Rates SM; Trocóniz I; Dalla Costa T
J Pharmacol Exp Ther; 2020 Oct; 375(1):49-58. PubMed ID: 32719070
[TBL] [Abstract][Full Text] [Related]
19. Precision dosing-based optimisation of paroxetine during pregnancy for poor and ultrarapid CYP2D6 metabolisers: a virtual clinical trial pharmacokinetics study.
Almurjan A; Macfarlane H; Badhan RKS
J Pharm Pharmacol; 2020 Aug; 72(8):1049-1060. PubMed ID: 32346890
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent effect of lamotrigine on quetiapine serum concentration in patients using instant release tablets.
Hole K; Lorentsen SK; Nordby KL; Slettvik M; Sørum IT; Molden E; Haslemo T
Eur J Clin Pharmacol; 2024 Jun; 80(6):839-845. PubMed ID: 38396309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]